Skip to content

Public FDA record

Z-0663-2020: VNS Therapy Program GMDN: 44077 Model # 3000 V1.5.2, RxOnly

Recall record Z-0663-2020 for LivaNova USA Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0663-2020
Company in FDA record
LivaNova USA Inc
FDA record creation date
Dec 10, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

This recall is being initiated due to reports that that the therapy programming tablet with software version 1.5 errantly performs a normal mode diagnostic test instead of the selected system diagnostic test on Model 102 and Model 102R devices, if the output current is greater than 0.5mA. This can result in false high impedance values during patient follow-up.

Source facts

Action
On November 16, 2018 LivaNova mailed a "Medical Device Correction" letter via 1st class mail to affected Doctors informing them about the recall. The letter asked doctor's to do the following: 1.When performing System Diagnostics on patients implanted with a Model 102 or 102R generator, do one of the following: a. Use any of the following Programming System software versions: Model 250 8.1/11.0; Model 3000 version 1.0; or b. If one of the above Programming Systems software versions is not available, complete the following steps to perform System Diagnostics using Model 3000 version 1.5 software: i. Interrogate the device, noting the devices current settings, ii. Program normal mode output current to 0mA, iii. Perform System Diagnostics as usual, iv. Re-interrogate the device, v. Program the devices normal mode output current back to the settings noted in step (i) above, and; vi. Interrogate the device to verify settings are as intended prior to the patient leaving the office visit. 2. Please complete and return the attached Customer Response Form by fax to 281-853-1248 or by e-mail to M3000FieldAction@livanova.com. 3. Please ensure that this notice is communicated to all personnel within your organization who need to be aware of it. 4. For questions regarding the information in this letter, please contact Clinical Technical Support at (866) 882-8804 (Monday to Friday, 8 AM to 5 PM CST) or e-mail at cservices@livanova.com.
Initiated
2018-11-16
Root cause
Software design
Distribution
IL, AK, AL, AR, AZ, CA, CA , CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD MI, MN, MO, MS, MT, NC, ND, NE, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WA , WI, WV, WY,
Recall number
Z-0663-2020
Recall status
Open, Classified
CDRH record ID
177461
FDA record created
2019-12-10
Recall event number
84170

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗